HIT paradigms and paradoxes

Area of Science:

• Hematology
• Immunology
• Pharmacology

Background:

• Heparin-induced thrombocytopenia (HIT) is an immune-mediated adverse drug reaction.
• The central paradigm involves antibodies against platelet factor 4 (PF4)/heparin complexes.
• Overdiagnosis of HIT is a significant clinical problem, particularly with modern diagnostic assays.

Purpose of the Study:

• To analyze the diagnostic challenges and paradoxes associated with HIT.
• To explore the factors influencing the immune response in HIT.
• To discuss the clinical implications and management of HIT.

Main Methods:

• Review of prospective studies on HIT antibody detection and platelet activation.
• Analysis of PF4-dependent immunoassay sensitivity and specificity.
• Examination of clinical data regarding HIT manifestations and treatment responses.

Main Results:

• A minority of sera with anti-PF4/heparin antibodies exhibit platelet-activating properties.
• PF4-dependent immunoassays, while sensitive, detect non-activating antibodies, leading to overdiagnosis.
• HIT presents paradoxes, including venous thrombosis predominance and delayed-onset worsening.

Conclusions:

• Washed platelet activation assays remain the gold standard for HIT diagnosis.
• Understanding HIT immune response factors is crucial for accurate diagnosis and management.
• Despite its complexities, many patients with prior HIT can safely receive heparin in the future.